Cardioxane-ICRF-187 towards anticancer drug specificity through selective toxicity reduction

J. Koning*, P. Palmer, C. R. Franks, D. E. Mulder, J. L. Speyer, M. D. Green, K. Hellmann

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-19
Number of pages19
JournalCancer Treatment Reviews
Issue number1
StatePublished - Mar 1991
Externally publishedYes

Cite this